Paediatric radiotherapy in Australia and New Zealand: An anachronism in 2003?

Australasian Radiology

Volumn 47, Issue 4, 2003, Pages 343-348

  Ahern, Verity ^a   Berry, Martin ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Paediatrics; Radiotherapy

Indexed keywords

AUSTRALIA; BRAIN STEM; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; GAMMA RADIATION; GERM CELL; GLIOMA; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDULLOBLASTOMA; NEW ZEALAND; PEDIATRICS; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; VISUAL SYSTEM;

AUSTRALIA; HUMANS; NEOPLASMS; NEW ZEALAND; PEDIATRICS; RADIOTHERAPY; SOCIETIES, MEDICAL;

EID: 0346461687     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1673.2003.01200.x     Document Type: Review

References (20)

1. Sexton M, Tiedemann K, Rigutoo G. Review of 47 patients treated on the ANZCCSG Ewings Sarcoma Study from November 1990 to November 1998 who received radiation therapy to the primary site of disease. Med Pediatr Oncol 2001; 37: 177.
2. Back MF. Influence of radiation time/dose factors on outcome for childhood medulloblastoma. Med Pediatr Oncol 2001; 37: 186.
3. Koh E-S, Ahern V, Gebski V, Sathaiyaseelan Y. Paediatric medulloblastoma in Australia and New Zealand: patterns of care in radiotherapy. Med Pediatr Oncol 2001; 37: 248.
4. Ris LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (eds). SEER Cancer Statistics Review 1973-1999. National Cancer Institute, Bethesda, MD, 2002. Available at URL: http://seer.cancer.gov/csr/1973_1999/,2002
5. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355.
6. Donaldson SS. A discourse: the 2002 Wataru W. Sutow Lecture Hodgkin Disease in children - perspectives and progress. Med Pediatr Oncol 2003; 40: 73-81.
7. Diller L, Nancarrow CM, Shaffer K et al. Breast cancer screening in women previously treated for Hodgkin's Disease: a prospective cohort study. J Clin Oncol 2002; 20: 2085-91.
8. Donaldson SS, Hudson MM, Lamborn KR et al. VAMP and low-dose involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 2002; 20: 3081-7.
9. Krischer JP, Ragab AH, Kun L et al. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991; 74: 905-9.
10. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma, the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP 1). Eur J Cancer 1990; 26: 464-9.
11. Packer RJ, Goldwein J, Nicholson HS et al. Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 1999; 17: 2127-36.
12. Strother D, Ashley D, Kellie SJ et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumour after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 2001; 19: 2696-704.
13. Thomas PRM, Deutsch M, Kepner JL et al. Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuroaxis irradiation. J Clin Oncol 2000; 18: 3004-11.
14. Mulhem RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group Study. J Clin Oncol 1998; 16: 1723-8.
15. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group Study. J Clin Oncol 2001; 19: 3470-76.
16. Taylor RE, Bailey CC, Lucraft H, Robinson K, Weston C, Gilbertson R, Lashford LS. Results of a randomised study of preradiotherapy chemotherapy (carboplatin, vincristine, cyclophosphamide, etoposide) with radiotherapy alone in Chang stage M0/1 medulloblastoma (SIOP/UKCCSG PNET-3). Med Pediatr Oncol 2001; 37: 191.
17. Bouffet E, Perilongo G, Canete A, Massimino M. Position paper, Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998; 30: 319-31.
18. Grill J, Le Deley M-C, Gambarelli D et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol; 2001; 19: 1288-96.
19. Merchant TE, Jenkins JJ, Burger PC et al. Influence of tumour grade on time to progression after irradiation for localized ependymoma in children. Int J Radiat Oncol Biol Phys 2002; 53: 52-7.
20. Hong A, Stevens G, Stalley P et al. Extracorporeal irradiation for malignant bone tumours. Int J Radiat Oncol Biol Phys 2001; 50: 441-7.